Xylem Reports Solid Earnings Growth on Five Percent Organic Revenue Increase
- Second quarter 2019 reported net income was
$139 million or$0.77 per share; Adjusted net income for the quarter was$143 million or$0.79 per share, up 10% excluding foreign exchange translation - Delivered
$1.3 billion in revenue for the second quarter, up 5% organically - Narrows full-year 2019 organic revenue growth guidance range to 5% to 6% and adjusted earnings per share to
$3.12 to $3.22
Decker continued, “We are confident that our Xylem team will continue to deliver mid-single-digit growth and strong margin expansion in the second half of the year, despite seeing some slowing in
Full-year 2019 Outlook
Xylem is updating its forecasted full-year 2019 revenue outlook to be in the range of
Xylem is revising its full-year 2019 adjusted operating margin outlook from 14.5 to 14.9 percent to 14.3 to 14.5 percent. The full-year adjusted earnings per share is now expected to be
Second Quarter Segment Results
Water Infrastructure
Xylem’s Water Infrastructure segment consists of its portfolio of businesses primarily serving wastewater operations for utility and industrial customers through transport, dewatering and treatment applications.
-
Second quarter 2019 revenue was
$561 million , up 6 percent organically compared with second quarter 2018. Double-digit growth in the U.S. from strength in the utilities and industrial end-markets led the performance in the quarter, partially offset by a slight decline inWestern Europe . -
Second quarter reported operating income for the segment was
$98 million and adjusted operating income, which excludes$9 million of restructuring and realignment costs, was$107 million . The segment’s reported operating margin was 17.5 percent and adjusted operating margin was 19.1 percent, up 130 basis points versus the prior year as productivity, price realization and volume leverage offset inflation, unfavorable mix and growth investments.
Applied Water
Xylem’s Applied Water segment consists of its portfolio of businesses primarily serving the end users of water through industrial water management, commercial building services and residential applications.
-
Second quarter 2019 Applied Water revenue was
$394 million , a 4 percent increase organically year-over-year, driven by healthy commercial and industrial end markets in the U.S. and Emerging Markets. Commercial was strong across most geographies from project activity. -
Second quarter reported operating income for the segment was
$62 million and adjusted operating income, which excludes$4 million of restructuring and realignment costs, was$66 million . The segment’s reported operating margin was 15.7 percent and adjusted operating margin was 16.8 percent, a 60 basis point increase over prior year period. Productivity and price realization more than offset inflation and unfavorable mix.
Measurement & Control Solutions
Xylem’s Measurement & Control Solutions segment consists of its portfolio of businesses primarily serving the clean water and energy operations for utility and industrial customers through smart metering, network technologies, advanced infrastructure analytics and analytic instrumentation applications.
-
Second quarter 2019 Measurement & Control Solutions revenue was
$390 million , up 6 percent organically versus the prior year. Revenue growth was driven by strength in the North American water business. -
Second quarter reported operating income for the segment was
$26 million , and adjusted operating income, which excludes$8 million of restructuring and realignment costs, was$34 million . The segment’s reported operating margin was 6.7 percent. Adjusted operating margin was 8.7 percent, down 40 basis points versus the prior year as higher volume, price realization and productivity were more than offset by unfavorable mix and investments for growth in our new AIA platform and the pursuit of large AMI deployments.
Supplemental information on Xylem’s second quarter 2019 earnings and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.
About Xylem
Xylem (XYL) is a leading global water technology company committed to developing innovative technology solutions to the world’s water challenges. The Company’s products and services move, treat, analyze, monitor and return water to the environment in public utility, industrial, residential and commercial building services settings. Xylem also provides a leading portfolio of smart metering, network technologies and advanced infrastructure analytics solutions for water, electric and gas utilities. The Company’s approximately 17,000 employees bring broad applications expertise with a strong focus on identifying comprehensive, sustainable solutions. Headquartered in
The name Xylem is derived from classical Greek and is the tissue that transports water in plants, highlighting the engineering efficiency of our water-centric business by linking it with the best water transportation of all – that which occurs in nature. For more information, please visit us at www.xylem.com.
Forward-Looking Statements
This press release contains information that may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “forecast,” “believe,” “target,” “will,” “could,” “would,” “should” and similar expressions identify forward-looking statements. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. These forward-looking statements include any statements that are not historical in nature, including any statements about the capitalization of
Factors that could cause results to differ materially from those anticipated include: overall economic and business conditions, political and other risks associated with our international operations, including military actions, economic sanctions or trade barriers including tariffs and embargoes that could affect customer markets and our business, and non-compliance with laws, including foreign corrupt practice laws, export and import laws and competition laws; potential for unexpected cancellations or delays of customer orders in our reported backlog; our exposure to fluctuations in foreign currency exchange rates; competition and pricing pressures in the markets we serve; the strength of housing and related markets; weather conditions; ability to retain and attract talent and key members of management; our relationship with and the performance of our channel partners; our ability to successfully identify, complete and integrate acquisitions; our ability to borrow or to refinance our existing indebtedness and availability of liquidity sufficient to meet our needs; uncertainty from the expected discontinuance of LIBOR and transition to any other interest rate benchmark; changes in the value of goodwill or intangible assets; risks relating to product defects, product liability and recalls; claims or investigations by governmental or regulatory bodies; security breaches or other disruptions of our information technology systems; litigation and contingent liabilities; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended
All forward-looking statements made herein are based on information currently available to the Company. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
|
XYLEM INC. AND SUBSIDIARIES |
|||||||||||||||
|
CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited) |
|||||||||||||||
|
(in millions, except per share data) |
|||||||||||||||
|
|
Three Months |
|
Six Months |
||||||||||||
|
For the period ended June 30, |
2019 |
|
2018 |
|
2019 |
|
2018 |
||||||||
|
Revenue |
$ |
1,345 |
|
|
$ |
1,317 |
|
|
$ |
2,582 |
|
|
$ |
2,534 |
|
|
Cost of revenue |
819 |
|
|
798 |
|
|
1,582 |
|
|
1,555 |
|
||||
|
Gross profit |
526 |
|
|
519 |
|
|
1,000 |
|
|
979 |
|
||||
|
Selling, general and administrative expenses |
294 |
|
|
293 |
|
|
597 |
|
|
589 |
|
||||
|
Research and development expenses |
47 |
|
|
50 |
|
|
98 |
|
|
91 |
|
||||
|
Restructuring and asset impairment charges |
14 |
|
|
5 |
|
|
25 |
|
|
15 |
|
||||
|
Operating income |
171 |
|
|
171 |
|
|
280 |
|
|
284 |
|
||||
|
Interest expense |
18 |
|
|
21 |
|
|
36 |
|
|
42 |
|
||||
|
Other non-operating income, net |
3 |
|
|
2 |
|
|
5 |
|
|
5 |
|
||||
|
Gain (loss) from sale of business |
— |
|
|
(2 |
) |
|
1 |
|
|
(2 |
) |
||||
|
Income before taxes |
156 |
|
|
150 |
|
|
250 |
|
|
245 |
|
||||
|
Income tax expense |
17 |
|
|
35 |
|
|
32 |
|
|
51 |
|
||||
|
Net income |
$ |
139 |
|
|
$ |
115 |
|
|
218 |
|
|
194 |
|
||
|
Earnings per share: |
|
|
|
|
|
|
|
||||||||
|
Basic |
$ |
0.77 |
|
|
$ |
0.64 |
|
|
$ |
1.21 |
|
|
$ |
1.08 |
|
|
Diluted |
$ |
0.77 |
|
|
$ |
0.64 |
|
|
$ |
1.20 |
|
|
$ |
1.07 |
|
|
Weighted average number of shares: |
|
|
|
|
|
|
|
||||||||
|
Basic |
180.0 |
|
|
179.8 |
|
|
179.9 |
|
|
179.8 |
|
||||
|
Diluted |
181.2 |
|
|
181.0 |
|
|
181.1 |
|
|
181.2 |
|
||||
|
XYLEM INC. AND SUBSIDIARIES |
|||||||
|
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) |
|||||||
|
(in millions, except per share amounts) |
|||||||
|
|
June 30,
|
|
December 31,
|
||||
|
|
|
|
|
||||
|
ASSETS |
|
|
|
||||
|
Current assets: |
|
|
|
||||
|
Cash and cash equivalents |
$ |
383 |
|
|
$ |
296 |
|
|
Receivables, less allowances for discounts and doubtful accounts of $31 and $35 in 2019 and 2018, respectively |
1,096 |
|
|
1,031 |
|
||
|
Inventories |
604 |
|
|
595 |
|
||
|
Prepaid and other current assets |
175 |
|
|
172 |
|
||
|
Total current assets |
2,258 |
|
|
2,094 |
|
||
|
Property, plant and equipment, net |
661 |
|
|
656 |
|
||
|
Goodwill |
2,999 |
|
|
2,976 |
|
||
|
Other intangible assets, net |
1,211 |
|
|
1,232 |
|
||
|
Other non-current assets |
545 |
|
|
264 |
|
||
|
Total assets |
$ |
7,674 |
|
|
$ |
7,222 |
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
||||
|
Current liabilities: |
|
|
|
||||
|
Accounts payable |
$ |
539 |
|
|
$ |
586 |
|
|
Accrued and other current liabilities |
596 |
|
|
546 |
|
||
|
Short-term borrowings and current maturities of long-term debt |
402 |
|
|
257 |
|
||
|
Total current liabilities |
1,537 |
|
|
1,389 |
|
||
|
Long-term debt |
2,051 |
|
|
2,051 |
|
||
|
Accrued postretirement benefits |
396 |
|
|
400 |
|
||
|
Deferred income tax liabilities |
305 |
|
|
303 |
|
||
|
Other non-current accrued liabilities |
479 |
|
|
297 |
|
||
|
Total liabilities |
4,768 |
|
|
4,440 |
|
||
|
|
|
|
|
||||
|
Stockholders’ equity: |
|
|
|
||||
|
Common Stock – par value $0.01 per share: |
|
|
|
||||
|
Authorized 750.0 shares, issued 193.8 shares and 192.9 shares in 2019 and 2018, respectively |
2 |
|
|
2 |
|
||
|
Capital in excess of par value |
1,975 |
|
|
1,950 |
|
||
|
Retained earnings |
1,770 |
|
|
1,639 |
|
||
|
Treasury stock – at cost 13.7 shares and 13.2 shares in 2019 and 2018, respectively |
(526 |
) |
|
(487 |
) |
||
|
Accumulated other comprehensive loss |
(327 |
) |
|
(336 |
) |
||
|
Total stockholders’ equity |
2,894 |
|
|
2,768 |
|
||
|
Non-controlling interests |
12 |
|
|
14 |
|
||
|
Total equity |
2,906 |
|
|
2,782 |
|
||
|
Total liabilities and stockholders’ equity |
$ |
7,674 |
|
|
$ |
7,222 |
|
|
XYLEM INC. AND SUBSIDIARIES |
|||||||||
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) |
|||||||||
|
(in millions) |
|||||||||
|
For the six months ended June 30, |
2019 |
|
2018 |
||||||
|
Operating Activities |
|
|
|
||||||
|
Net income |
$ |
218 |
|
|
$ |
194 |
|
||
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
||||||
|
Depreciation |
58 |
|
|
58 |
|
||||
|
Amortization |
69 |
|
|
74 |
|
||||
|
Share-based compensation |
16 |
|
|
16 |
|
||||
|
Restructuring and asset impairment charges |
25 |
|
|
15 |
|
||||
|
(Gain) loss from sale of businesses |
(1 |
) |
|
2 |
|
||||
|
Other, net |
4 |
|
|
(7 |
) |
||||
|
Payments for restructuring |
(12 |
) |
|
(12 |
) |
||||
|
Changes in assets and liabilities (net of acquisitions): |
|
|
|
||||||
|
Changes in receivables |
(68 |
) |
|
(68 |
) |
||||
|
Changes in inventories |
(10 |
) |
|
(87 |
) |
||||
|
Changes in accounts payable |
(23 |
) |
|
54 |
|
||||
|
Other, net |
(70 |
) |
|
(38 |
) |
||||
|
Net Cash – Operating activities |
206 |
|
|
201 |
|
||||
|
Investing Activities |
|
|
|
||||||
|
Capital expenditures |
(129 |
) |
|
(111 |
) |
||||
|
Acquisitions of businesses, net of cash acquired |
(18 |
) |
|
(430 |
) |
||||
|
Proceeds from sale of business |
(2 |
) |
|
— |
|
||||
|
Other, net |
3 |
|
|
4 |
|
||||
|
Net Cash – Investing activities |
(146 |
) |
|
(537 |
) |
||||
|
Financing Activities |
|
|
|
||||||
|
Short-term debt issued, net |
257 |
|
|
437 |
|
||||
|
Short-term debt repaid |
(113) |
|
|
(54 |
) |
||||
|
Repurchase of common stock |
(39 |
) |
|
(58 |
) |
||||
|
Proceeds from exercise of employee stock options |
8 |
|
|
4 |
|
||||
|
Dividends paid |
(87 |
) |
|
(76 |
) |
||||
|
Other, net |
(1 |
) |
|
(1 |
) |
||||
|
Net Cash – Financing activities |
25 |
|
|
252 |
|
||||
|
Effect of exchange rate changes on cash |
2 |
|
|
(9 |
) |
||||
|
Net change in cash and cash equivalents |
87 |
|
|
(93 |
) |
||||
|
Cash and cash equivalents at beginning of year |
296 |
|
|
414 |
|
||||
|
Cash and cash equivalents at end of period |
$ |
383 |
|
|
$ |
321 |
|
||
|
Supplemental disclosure of cash flow information: |
|
|
|
||||||
|
Cash paid during the period for: |
|
|
|
||||||
|
Interest |
$ |
45 |
|
|
$ |
46 |
|
||
|
Income taxes (net of refunds received) |
$ |
74 |
|
|
$ |
51 |
|
||
|
XYLEM INC. AND SUBSIDIARIES |
|||||||||||||||
|
CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited) |
|||||||||||||||
|
(in millions, except per share data) |
|||||||||||||||
|
|
Three Months |
|
Six Months |
||||||||||||
|
For the period ended June 30, |
2019 |
|
2018 |
|
2019 |
|
2018 |
||||||||
|
Revenue |
$ |
1,345 |
|
|
$ |
1,317 |
|
|
$ |
2,582 |
|
|
$ |
2,534 |
|
|
Cost of revenue |
819 |
|
|
798 |
|
|
1,582 |
|
|
1,555 |
|
||||
|
Gross profit |
526 |
|
|
519 |
|
|
1,000 |
|
|
979 |
|
||||
|
Selling, general and administrative expenses |
294 |
|
|
293 |
|
|
597 |
|
|
589 |
|
||||
|
Research and development expenses |
47 |
|
|
50 |
|
|
98 |
|
|
91 |
|
||||
|
Restructuring and asset impairment charges |
14 |
|
|
5 |
|
|
25 |
|
|
15 |
|
||||
|
Operating income |
171 |
|
|
171 |
|
|
280 |
|
|
284 |
|
||||
|
Interest expense |
18 |
|
|
21 |
|
|
36 |
|
|
42 |
|
||||
|
Other non-operating income, net |
3 |
|
|
2 |
|
|
5 |
|
|
5 |
|
||||
|
Gain (loss) from sale of business |
— |
|
|
(2 |
) |
|
1 |
|
|
(2 |
) |
||||
|
Income before taxes |
156 |
|
|
150 |
|
|
250 |
|
|
245 |
|
||||
|
Income tax expense |
17 |
|
|
35 |
|
|
32 |
|
|
51 |
|
||||
|
Net income |
$ |
139 |
|
|
$ |
115 |
|
|
218 |
|
|
194 |
|
||
|
Earnings per share: |
|
|
|
|
|
|
|
||||||||
|
Basic |
$ |
0.77 |
|
|
$ |
0.64 |
|
|
$ |
1.21 |
|
|
$ |
1.08 |
|
|
Diluted |
$ |
0.77 |
|
|
$ |
0.64 |
|
|
$ |
1.20 |
|
|
$ |
1.07 |
|
|
Weighted average number of shares: |
|
|
|
|
|
|
|
||||||||
|
Basic |
180.0 |
|
|
179.8 |
|
|
179.9 |
|
|
179.8 |
|
||||
|
Diluted |
181.2 |
|
|
181.0 |
|
|
181.1 |
|
|
181.2 |
|
||||
|
XYLEM INC. AND SUBSIDIARIES |
|||||||
|
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) |
|||||||
|
(in millions, except per share amounts) |
|||||||
|
|
June 30,
|
|
December 31,
|
||||
|
|
|
|
|
||||
|
ASSETS |
|
|
|
||||
|
Current assets: |
|
|
|
||||
|
Cash and cash equivalents |
$ |
383 |
|
|
$ |
296 |
|
|
Receivables, less allowances for discounts and doubtful accounts of $31 and $35 in 2019 and 2018, respectively |
1,096 |
|
|
1,031 |
|
||
|
Inventories |
604 |
|
|
595 |
|
||
|
Prepaid and other current assets |
175 |
|
|
172 |
|
||
|
Total current assets |
2,258 |
|
|
2,094 |
|
||
|
Property, plant and equipment, net |
661 |
|
|
656 |
|
||
|
Goodwill |
2,999 |
|
|
2,976 |
|
||
|
Other intangible assets, net |
1,211 |
|
|
1,232 |
|
||
|
Other non-current assets |
545 |
|
|
264 |
|
||
|
Total assets |
$ |
7,674 |
|
|
$ |
7,222 |
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
||||
|
Current liabilities: |
|
|
|
||||
|
Accounts payable |
$ |
539 |
|
|
$ |
586 |
|
|
Accrued and other current liabilities |
596 |
|
|
546 |
|
||
|
Short-term borrowings and current maturities of long-term debt |
402 |
|
|
257 |
|
||
|
Total current liabilities |
1,537 |
|
|
1,389 |
|
||
|
Long-term debt |
2,051 |
|
|
2,051 |
|
||
|
Accrued postretirement benefits |
396 |
|
|
400 |
|
||
|
Deferred income tax liabilities |
305 |
|
|
303 |
|
||
|
Other non-current accrued liabilities |
479 |
|
|
297 |
|
||
|
Total liabilities |
4,768 |
|
|
4,440 |
|
||
|
|
|
|
|
||||
|
Stockholders’ equity: |
|
|
|
||||
|
Common Stock – par value $0.01 per share: |
|
|
|
||||
|
Authorized 750.0 shares, issued 193.8 shares and 192.9 shares in 2019 and 2018, respectively |
2 |
|
|
2 |
|
||
|
Capital in excess of par value |
1,975 |
|
|
1,950 |
|
||
|
Retained earnings |
1,770 |
|
|
1,639 |
|
||
|
Treasury stock – at cost 13.7 shares and 13.2 shares in 2019 and 2018, respectively |
(526 |
) |
|
(487 |
) |
||
|
Accumulated other comprehensive loss |
(327 |
) |
|
(336 |
) |
||
|
Total stockholders’ equity |
2,894 |
|
|
2,768 |
|
||
|
Non-controlling interests |
12 |
|
|
14 |
|
||
|
Total equity |
2,906 |
|
|
2,782 |
|
||
|
Total liabilities and stockholders’ equity |
$ |
7,674 |
|
|
$ |
7,222 |
|
|
XYLEM INC. AND SUBSIDIARIES |
|||||||||
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) |
|||||||||
|
(in millions) |
|||||||||
|
For the six months ended June 30, |
2019 |
|
2018 |
||||||
|
Operating Activities |
|
|
|
||||||
|
Net income |
$ |
218 |
|
|
$ |
194 |
|
||
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
||||||
|
Depreciation |
58 |
|
|
58 |
|
||||
|
Amortization |
69 |
|
|
74 |
|
||||
|
Share-based compensation |
16 |
|
|
16 |
|
||||
|
Restructuring and asset impairment charges |
25 |
|
|
15 |
|
||||
|
(Gain) loss from sale of businesses |
(1 |
) |
|
2 |
|
||||
|
Other, net |
4 |
|
|
(7 |
) |
||||
|
Payments for restructuring |
(12 |
) |
|
(12 |
) |
||||
|
Changes in assets and liabilities (net of acquisitions): |
|
|
|
||||||
|
Changes in receivables |
(68 |
) |
|
(68 |
) |
||||
|
Changes in inventories |
(10 |
) |
|
(87 |
) |
||||
|
Changes in accounts payable |
(23 |
) |
|
54 |
|
||||
|
Other, net |
(70 |
) |
|
(38 |
) |
||||
|
Net Cash – Operating activities |
206 |
|
|
201 |
|
||||
|
Investing Activities |
|
|
|
||||||
|
Capital expenditures |
(129 |
) |
|
(111 |
) |
||||
|
Acquisitions of businesses, net of cash acquired |
(18 |
) |
|
(430 |
) |
||||
|
Proceeds from sale of business |
(2 |
) |
|
— |
|
||||
|
Other, net |
3 |
|
|
4 |
|
||||
|
Net Cash – Investing activities |
(146 |
) |
|
(537 |
) |
||||
|
Financing Activities |
|
|
|
||||||
|
Short-term debt issued, net |
257 |
|
|
437 |
|
||||
|
Short-term debt repaid |
(113) |
|
|
(54 |
) |
||||
|
Repurchase of common stock |
(39 |
) |
|
(58 |
) |
||||
|
Proceeds from exercise of employee stock options |
8 |
|
|
4 |
|
||||
|
Dividends paid |
(87 |
) |
|
(76 |
) |
||||
|
Other, net |
(1 |
) |
|
(1 |
) |
||||
|
Net Cash – Financing activities |
25 |
|
|
252 |
|
||||
|
Effect of exchange rate changes on cash |
2 |
|
|
(9 |
) |
||||
|
Net change in cash and cash equivalents |
87 |
|
|
(93 |
) |
||||
|
Cash and cash equivalents at beginning of year |
296 |
|
|
414 |
|
||||
|
Cash and cash equivalents at end of period |
$ |
383 |
|
|
$ |
321 |
|
||
|
Supplemental disclosure of cash flow information: |
|
|
|
||||||
|
Cash paid during the period for: |
|
|
|
||||||
|
Interest |
$ |
45 |
|
|
$ |
46 |
|
||
|
Income taxes (net of refunds received) |
$ |
74 |
|
|
$ |
51 |
|
||
Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following non-GAAP measures, which may not be comparable to similarly titled measures reported by other companies, to be key performance indicators:
“Organic revenue" and "Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.
“Constant currency” defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.
“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” reflects the adjustment to EBITDA to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.
"Adjusted Operating Income", "Adjusted Segment Operating Income", "Adjusted Net Income" and “Adjusted EPS” defined as operating income, segment operating income, net income and earnings per share, adjusted to exclude restructuring and realignment costs, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.
“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flow, less capital expenditures as well as adjustments for other significant items that impact current results which management believes are not related to our ongoing operations and performance. Our definition of "free cash flow" does not consider certain non-discretionary cash payments, such as debt.
“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.
“Sensus Acquisition Related Costs" defined as costs incurred by the Company associated with the acquisition of Sensus that are being reported within operating income. These costs include integration costs, acquisition costs, costs related to the recognition of the backlog intangible asset amortization recorded in purchase accounting.
“Special charges" defined as costs incurred by the Company, such as acquisition and integration related costs not included in "Sensus Acquisition Related Costs", non-cash impairment charges and other special non-operating items.
“Tax-related special items" defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, significant reserves for cash repatriation, excess tax benefits/losses and other discrete tax adjustments.
| Reported vs. Organic & Constant Currency Orders | ||||||||||||||||||
| ($ Millions) | ||||||||||||||||||
| (As Reported - GAAP) | (As Adjusted - Organic) | Constant Currency | ||||||||||||||||
| (A) | (B) | (C) | (D) | (E) = B+C+D | (F) = E/A | (G) = (E - C) / A | ||||||||||||
| Change | % Change | Acquisitions / Divestitures |
Change | % Change | ||||||||||||||
| Orders | Orders | 2019 v. 2018 | 2019 v. 2018 | FX Impact | Adj. 2019 v. 2018 | Adj. 2019 v. 2018 | ||||||||||||
|
2019 |
2018 |
|||||||||||||||||
| Six Months Ended June 30 | ||||||||||||||||||
| Xylem Inc. |
2,707 |
2,698 |
9 |
|
0% |
9 |
89 |
107 |
4% |
4% |
||||||||
| Water Infrastructure |
1,118 |
1,134 |
(16 |
) |
-1% |
- |
51 |
35 |
3% |
3% |
||||||||
| Applied Water |
793 |
785 |
8 |
|
1% |
- |
20 |
28 |
4% |
4% |
||||||||
| Measurement & Control Solutions |
796 |
779 |
17 |
|
2% |
9 |
18 |
44 |
6% |
4% |
||||||||
| Quarter Ended June 30 | ||||||||||||||||||
| Xylem Inc. |
1,392 |
1,378 |
14 |
|
1% |
7 |
33 |
54 |
4% |
3% |
||||||||
| Water Infrastructure |
586 |
580 |
6 |
|
1% |
- |
16 |
22 |
4% |
4% |
||||||||
| Applied Water |
399 |
401 |
(2 |
) |
0% |
- |
8 |
6 |
1% |
1% |
||||||||
| Measurement & Control Solutions |
407 |
397 |
10 |
|
3% |
7 |
9 |
26 |
7% |
5% |
||||||||
| Quarter Ended March 31 | ||||||||||||||||||
| Xylem Inc. |
1,315 |
1,320 |
(5 |
) |
0% |
2 |
56 |
53 |
4% |
4% |
||||||||
| Water Infrastructure |
532 |
554 |
(22 |
) |
-4% |
- |
35 |
13 |
2% |
2% |
||||||||
| Applied Water |
394 |
384 |
10 |
|
3% |
- |
12 |
22 |
6% |
6% |
||||||||
| Measurement & Control Solutions |
389 |
382 |
7 |
|
2% |
2 |
9 |
18 |
5% |
4% |
||||||||
| Xylem Inc. Non-GAAP Reconciliation | |||||||||||||||||
| Reported vs. Organic & Constant Currency Revenue | |||||||||||||||||
| ($ Millions) | |||||||||||||||||
| (As Reported - GAAP) | (As Adjusted - Organic) | Constant Currency | |||||||||||||||
| (A) | (B) | (C) | (D) | (E) = B+C+D | (F) = E/A | (G) = (E - C) / A | |||||||||||
| Change | % Change | Acquisitions / Divestitures |
Change | % Change | |||||||||||||
| Revenue | Revenue | 2019 v. 2018 | 2019 v. 2018 | FX Impact | Adj. 2019 v. 2018 | Adj. 2019 v. 2018 | |||||||||||
|
2019 |
2018 |
||||||||||||||||
| Six Months Ended June 30 | |||||||||||||||||
| Xylem Inc. |
2,582 |
2,534 |
48 |
2% |
14 |
83 |
145 |
6% |
5% |
||||||||
| Water Infrastructure |
1,043 |
1,026 |
17 |
2% |
- |
46 |
63 |
6% |
6% |
||||||||
| Applied Water |
773 |
754 |
19 |
3% |
- |
20 |
39 |
5% |
5% |
||||||||
| Measurement & Control Solutions |
766 |
754 |
12 |
2% |
14 |
17 |
43 |
6% |
4% |
||||||||
| Quarter Ended June 30 | |||||||||||||||||
| Xylem Inc. |
1,345 |
1,317 |
28 |
2% |
9 |
32 |
69 |
5% |
5% |
||||||||
| Water Infrastructure |
561 |
546 |
15 |
3% |
- |
16 |
31 |
6% |
6% |
||||||||
| Applied Water |
394 |
388 |
6 |
2% |
- |
8 |
14 |
4% |
4% |
||||||||
| Measurement & Control Solutions |
390 |
383 |
7 |
2% |
9 |
8 |
24 |
6% |
4% |
||||||||
| Quarter Ended March 31 | |||||||||||||||||
| Xylem Inc. |
1,237 |
1,217 |
20 |
2% |
5 |
51 |
76 |
6% |
6% |
||||||||
| Water Infrastructure |
482 |
480 |
2 |
0% |
- |
30 |
32 |
7% |
7% |
||||||||
| Applied Water |
379 |
366 |
13 |
4% |
- |
12 |
25 |
7% |
7% |
||||||||
| Measurement & Control Solutions |
376 |
371 |
5 |
1% |
5 |
9 |
19 |
5% |
4% |
||||||||
| Xylem Inc. Non-GAAP Reconciliation | |||||||||
| Adjusted Operating Income | |||||||||
| ($ Millions) | |||||||||
|
Q1 |
|
Q2 |
|
YTD |
|||||
|
2019 |
2018 |
|
2019 |
2018 |
|
2019 |
2018 |
||
| Total Revenue | |||||||||
| • Total Xylem |
1,237 |
1,217 |
1,345 |
1,317 |
2,582 |
2,534 |
|||
| • Water Infrastructure |
482 |
480 |
561 |
546 |
1,043 |
1,026 |
|||
| • Applied Water |
379 |
366 |
394 |
388 |
773 |
754 |
|||
| • Measurement & Control Solutions |
376 |
371 |
390 |
383 |
766 |
754 |
|||
| Operating Income | |||||||||
| • Total Xylem |
109 |
113 |
171 |
171 |
280 |
284 |
|||
| • Water Infrastructure |
51 |
49 |
98 |
92 |
149 |
141 |
|||
| • Applied Water |
56 |
50 |
62 |
61 |
118 |
111 |
|||
| • Measurement & Control Solutions |
16 |
33 |
26 |
31 |
42 |
64 |
|||
| • Total Segments |
123 |
132 |
186 |
184 |
309 |
316 |
|||
| Operating Margin | |||||||||
| • Total Xylem |
8.8% |
9.3% |
12.7% |
13.0% |
10.8% |
11.2% |
|||
| • Water Infrastructure |
10.6% |
10.2% |
17.5% |
16.8% |
14.3% |
13.7% |
|||
| • Applied Water |
14.8% |
13.7% |
15.7% |
15.7% |
15.3% |
14.7% |
|||
| • Measurement & Control Solutions |
4.3% |
8.9% |
6.7% |
8.1% |
5.5% |
8.5% |
|||
| • Total Segments |
9.9% |
10.8% |
13.8% |
14.0% |
12.0% |
12.5% |
|||
| Special Charges | |||||||||
| • Total Xylem |
4 |
6 |
- |
1 |
4 |
7 |
|||
| • Water Infrastructure |
- |
- |
- |
- |
- |
- |
|||
| • Applied Water |
- |
- |
- |
- |
- |
- |
|||
| • Measurement & Control Solutions |
4 |
2 |
- |
1 |
4 |
3 |
|||
| • Total Segments |
4 |
2 |
- |
1 |
4 |
3 |
|||
| Restructuring & Realignment Costs | |||||||||
| • Total Xylem |
20 |
16 |
21 |
10 |
41 |
26 |
|||
| • Water Infrastructure |
9 |
5 |
9 |
5 |
18 |
10 |
|||
| • Applied Water |
3 |
3 |
4 |
2 |
7 |
5 |
|||
| • Measurement & Control Solutions |
8 |
8 |
8 |
3 |
16 |
11 |
|||
| • Total Segments |
20 |
16 |
21 |
10 |
41 |
26 |
|||
| Adjusted Operating Income | |||||||||
| • Total Xylem |
133 |
135 |
192 |
182 |
325 |
317 |
|||
| • Water Infrastructure |
60 |
54 |
107 |
97 |
167 |
151 |
|||
| • Applied Water |
59 |
53 |
66 |
63 |
125 |
116 |
|||
| • Measurement & Control Solutions |
28 |
43 |
34 |
35 |
62 |
78 |
|||
| • Total Segments |
147 |
150 |
207 |
195 |
354 |
345 |
|||
| Adjusted Operating Margin | |||||||||
| • Total Xylem |
10.8% |
11.1% |
14.3% |
13.8% |
12.6% |
12.5% |
|||
| • Water Infrastructure |
12.4% |
11.3% |
19.1% |
17.8% |
16.0% |
14.7% |
|||
| • Applied Water |
15.6% |
14.5% |
16.8% |
16.2% |
16.2% |
15.4% |
|||
| • Measurement & Control Solutions |
7.4% |
11.6% |
8.7% |
9.1% |
8.1% |
10.3% |
|||
| • Total Segments |
11.9% |
12.3% |
15.4% |
14.8% |
13.7% |
13.6% |
|||
| Xylem Inc. Non-GAAP Reconciliation | ||||||||||||||||||||||||
| Adjusted Diluted EPS | ||||||||||||||||||||||||
| ($ Millions, except per share amounts) | ||||||||||||||||||||||||
|
Q2 2019 |
|
Q2 2018 |
||||||||||||||||||||||
|
As Reported |
|
Adjustments |
|
Adjusted |
|
As Reported |
|
Adjustments |
|
Adjusted |
||||||||||||||
| Total Revenue |
|
1,345 |
|
|
- |
|
|
1,345 |
|
|
1,317 |
|
|
- |
|
|
1,317 |
|
||||||
| Operating Income |
|
171 |
|
|
21 |
|
a |
|
192 |
|
|
171 |
|
|
11 |
|
a |
|
182 |
|
||||
| Operating Margin |
|
12.7 |
% |
|
14.3 |
% |
|
13.0 |
% |
|
13.8 |
% |
||||||||||||
| Interest Expense |
|
(18 |
) |
|
- |
|
|
(18 |
) |
|
(21 |
) |
|
- |
|
|
(21 |
) |
||||||
| Other Non-Operating Income (Expense) |
|
3 |
|
|
- |
|
|
3 |
|
|
2 |
|
|
- |
|
|
2 |
|
||||||
| Gain/(Loss) From Sale of Businesses |
|
- |
|
|
- |
|
|
- |
|
|
(2 |
) |
|
2 |
|
|
- |
|
||||||
| Income before Taxes |
|
156 |
|
|
21 |
|
|
177 |
|
|
150 |
|
|
13 |
|
|
163 |
|
||||||
| Provision for Income Taxes |
|
(17 |
) |
|
(17 |
) |
b |
|
(34 |
) |
|
(35 |
) |
|
3 |
|
b |
|
(32 |
) |
||||
| Net Income Attributable to Xylem |
|
139 |
|
|
4 |
|
|
143 |
|
|
115 |
|
|
16 |
|
|
131 |
|
||||||
| Diluted Shares |
|
181.2 |
|
|
181.2 |
|
|
181.0 |
|
|
181.0 |
|
||||||||||||
| Diluted EPS |
$ |
0.77 |
|
$ |
0.02 |
|
$ |
0.79 |
|
$ |
0.64 |
|
$ |
0.09 |
|
$ |
0.73 |
|
||||||
| Year-over-year currency translation impact on current year diluted EPS |
$ |
- |
|
$ |
(0.01 |
) |
$ |
(0.01 |
) |
|||||||||||||||
| Diluted EPS at Constant Currency |
$ |
0.77 |
|
$ |
0.03 |
|
$ |
0.80 |
|
|||||||||||||||
| Q2 YTD 2019 | Q2 YTD 2018 | |||||||||||||||||||||||
| As Reported | Adjustments | Adjusted | As Reported | Adjustments | Adjusted | |||||||||||||||||||
| Total Revenue |
|
2,582 |
|
|
- |
|
|
2,582 |
|
|
2,534 |
|
|
2,534 |
|
|||||||||
| Operating Income |
|
280 |
|
|
45 |
|
a |
|
325 |
|
|
284 |
|
|
33 |
|
a |
|
317 |
|
||||
| Operating Margin |
|
10.8 |
% |
|
12.6 |
% |
|
11.2 |
% |
|
12.5 |
% |
||||||||||||
| Interest Expense |
|
(36 |
) |
|
- |
|
|
(36 |
) |
|
(42 |
) |
|
- |
|
|
(42 |
) |
||||||
| Other Non-Operating Income (Expense) |
|
5 |
|
|
- |
|
|
5 |
|
|
5 |
|
|
- |
|
|
5 |
|
||||||
| Gain/(Loss) From Sale of Businesses |
|
1 |
|
|
(1 |
) |
|
- |
|
|
(2 |
) |
|
2 |
|
|
- |
|
||||||
| Income before Taxes |
|
250 |
|
|
44 |
|
|
294 |
|
|
245 |
|
|
35 |
|
|
280 |
|
||||||
| Provision for Income Taxes |
|
(32 |
) |
|
(25 |
) |
b |
|
(57 |
) |
|
(51 |
) |
|
(5 |
) |
b |
|
(56 |
) |
||||
| Net Income Attributable to Xylem |
|
218 |
|
|
19 |
|
|
237 |
|
|
194 |
|
|
30 |
|
|
224 |
|
||||||
| Diluted Shares |
|
181.1 |
|
|
181.1 |
|
|
181.2 |
|
|
181.2 |
|
||||||||||||
| Diluted EPS |
$ |
1.20 |
|
$ |
0.11 |
|
$ |
1.31 |
|
$ |
1.07 |
|
$ |
0.17 |
|
$ |
1.24 |
|
||||||
| Year-over-year currency translation impact on current year diluted EPS |
$ |
(0.05 |
) |
$ |
(0.01 |
) |
$ |
(0.06 |
) |
|||||||||||||||
| Diluted EPS at Constant Currency |
$ |
1.25 |
|
$ |
0.12 |
|
$ |
1.37 |
|
|||||||||||||||
| a | Quarter: Restructuring & realignment costs of $21 million and $10 million in 2019 and 2018, respectively; special charges of $1 million of acquisition related costs in 2018. | ||||||||||||
| Year-to-date: Restructuring & realignment costs of $41 million and $26 million in 2019 and 2018, respectively; special charges of $4 million of acquisition related costs in 2019 ($1 million of acquisition related costs and $3 million of intangible asset impairment) and $7 million of acquisition related costs in 2018. | |||||||||||||
| b | Quarter: Net tax impact on restructuring & realignment costs of $4 million and $3 million in 2019 and 2018, respectively and tax-related special items of $13 million of expense in 2019 and $6 million of benefit in 2018. | ||||||||||||
| Year-to-date: Net tax impact on restructuring & realignment costs of $8 million and $7 million in 2019 and 2018, respectively; net tax impact on special charges of $0 million and $1 million in 2019 and 2018, respectively; and tax-related special items of $17 million of expense and $3 million of benefit in 2019 and 2018, respectively. | |||||||||||||
| Xylem Inc. Non-GAAP Reconciliation | ||||||||||||||||||||||||
| Net Cash - Operating Activities vs. Free Cash Flow | ||||||||||||||||||||||||
| ($ Millions) | ||||||||||||||||||||||||
|
Q1 |
|
Q2 |
|
Year-to-Date |
||||||||||||||||||||
|
2019 |
|
2018 |
|
2019 |
|
2018 |
|
2019 |
|
2018 |
||||||||||||||
| Net Cash - Operating Activities |
$ |
83 |
|
$ |
63 |
|
$ |
123 |
|
$ |
138 |
|
$ |
206 |
|
$ |
201 |
|
||||||
| Capital Expenditures |
|
(69 |
) |
|
(61 |
) |
|
(60 |
) |
|
(50 |
) |
$ |
(129 |
) |
$ |
(111 |
) |
||||||
| Free Cash Flow |
$ |
14 |
|
$ |
2 |
|
$ |
63 |
|
$ |
88 |
|
$ |
77 |
|
$ |
90 |
|
||||||
| Cash paid for Sensus acquisition related costs |
|
- |
|
|
(1 |
) |
|
- |
|
|
- |
|
|
- |
|
|
(1 |
) |
||||||
| Free Cash Flow, excluding Sensus Acquisition Related Costs |
$ |
14 |
|
$ |
3 |
|
$ |
63 |
|
$ |
88 |
|
$ |
77 |
|
$ |
91 |
|
||||||
| Net Income |
|
79 |
|
|
79 |
|
|
139 |
|
|
115 |
|
|
218 |
|
|
194 |
|
||||||
| Gain/(Loss) from sale of businesses |
|
1 |
|
|
- |
|
|
- |
|
|
(2 |
) |
|
1 |
|
|
(2 |
) |
||||||
| Special Charges - non-cash impairment |
|
(3 |
) |
|
- |
|
|
- |
|
|
- |
|
|
(3 |
) |
|
- |
|
||||||
|
|
- |
|
|
- |
|
|
- |
|
||||||||||||||||
| Net Income, excluding gain on sale of businesses and non-cash impairment charges |
$ |
81 |
|
$ |
79 |
|
$ |
139 |
|
$ |
117 |
|
$ |
220 |
|
$ |
196 |
|
||||||
| Free Cash Flow Conversion |
|
17 |
% |
|
4 |
% |
|
45 |
% |
|
75 |
% |
|
35 |
% |
|
46 |
% |
||||||
| Xylem Inc. Non-GAAP Reconciliation | ||||||||||||||
| EBITDA and Adjusted EBITDA by Quarter | ||||||||||||||
| ($ Millions) | ||||||||||||||
|
2019 |
||||||||||||||
| Q1 | Q2 | Q3 | Q4 | Total | ||||||||||
| Net Income |
79 |
|
139 |
|
218 |
|
||||||||
| Income Tax Expense |
15 |
|
17 |
|
32 |
|
||||||||
| Interest Expense (Income), net |
17 |
|
18 |
|
35 |
|
||||||||
| Depreciation |
29 |
|
29 |
|
58 |
|
||||||||
| Amortization |
35 |
|
34 |
|
69 |
|
||||||||
| EBITDA |
175 |
|
237 |
|
- |
|
- |
|
412 |
|
||||
| Share-based Compensation |
9 |
|
7 |
|
16 |
|
||||||||
| Restructuring & Realignment |
20 |
|
21 |
|
41 |
|
||||||||
| Loss/(Gain) from sale of business |
(1 |
) |
- |
|
(1 |
) |
||||||||
| Special Charges |
4 |
|
- |
|
4 |
|
||||||||
| Adjusted EBITDA |
207 |
|
265 |
|
- |
|
- |
|
472 |
|
||||
| Revenue |
1,237 |
|
1,345 |
|
2,582 |
|
||||||||
| Adjusted EBITDA Margin |
16.7 |
% |
19.7 |
% |
18.3 |
% |
||||||||
|
2018 |
||||||||||||||
| Q1 | Q2 | Q3 | Q4 | Total | ||||||||||
| Net Income |
79 |
|
115 |
|
130 |
|
225 |
|
549 |
|
||||
| Income Tax Expense |
16 |
|
35 |
|
31 |
|
(46 |
) |
36 |
|
||||
| Interest Expense (Income), net |
20 |
|
20 |
|
20 |
|
18 |
|
78 |
|
||||
| Depreciation |
29 |
|
29 |
|
29 |
|
30 |
|
117 |
|
||||
| Amortization |
38 |
|
36 |
|
34 |
|
36 |
|
144 |
|
||||
| EBITDA |
182 |
|
235 |
|
244 |
|
263 |
|
924 |
|
||||
| Share-based Compensation |
9 |
|
7 |
|
7 |
|
7 |
|
30 |
|
||||
| Restructuring & Realignment |
16 |
|
9 |
|
11 |
|
11 |
|
47 |
|
||||
| Loss/(Gain) from sale of business |
- |
|
2 |
|
(2 |
) |
- |
|
- |
|
||||
| Special Charges |
6 |
|
1 |
|
1 |
|
4 |
|
12 |
|
||||
| Adjusted EBITDA |
213 |
|
254 |
|
261 |
|
285 |
|
1,013 |
|
||||
| Revenue |
1,217 |
|
1,317 |
|
1,287 |
|
1,386 |
|
5,207 |
|
||||
| Adjusted EBITDA Margin |
17.5 |
% |
19.3 |
% |
20.3 |
% |
20.6 |
% |
19.5 |
% |
||||
| Xylem Inc. Non-GAAP Reconciliation | ||||||||||||||
| EBITDA and Adjusted EBITDA by Quarter | ||||||||||||||
| Water Infrastructure | ||||||||||||||
| ($ Millions) | ||||||||||||||
|
2019 |
||||||||||||||
| Q1 | Q2 | Q3 | Q4 | Total | ||||||||||
| Pre-Tax Income |
50 |
|
96 |
|
146 |
|
||||||||
| Interest Expense (Income), net |
(1 |
) |
1 |
|
- |
|
||||||||
| Depreciation |
11 |
|
12 |
|
23 |
|
||||||||
| Amortization |
4 |
|
4 |
|
8 |
|
||||||||
| EBITDA |
64 |
|
113 |
|
- |
|
- |
|
177 |
|
||||
| Share-based Compensation |
1 |
|
- |
|
1 |
|
||||||||
| Restructuring & Realignment |
9 |
|
9 |
|
18 |
|
||||||||
| Adjusted EBITDA |
74 |
|
122 |
|
- |
|
- |
|
196 |
|
||||
| Revenue |
482 |
|
561 |
|
1,043 |
|
||||||||
| Adjusted EBITDA Margin |
15.4 |
% |
21.7 |
% |
18.8 |
% |
||||||||
|
2018 |
||||||||||||||
| Q1 | Q2 | Q3 | Q4 | Total | ||||||||||
| Pre-Tax Income |
47 |
|
90 |
|
98 |
|
117 |
|
352 |
|
||||
| Interest Expense (Income), net |
- |
|
(1 |
) |
(1 |
) |
- |
|
(2 |
) |
||||
| Depreciation |
12 |
|
11 |
|
12 |
|
11 |
|
46 |
|
||||
| Amortization |
5 |
|
5 |
|
5 |
|
5 |
|
20 |
|
||||
| EBITDA |
64 |
|
105 |
|
114 |
|
133 |
|
416 |
|
||||
| Share-based Compensation |
1 |
|
- |
|
1 |
|
- |
|
2 |
|
||||
| Restructuring & Realignment |
5 |
|
5 |
|
5 |
|
5 |
|
20 |
|
||||
| Adjusted EBITDA |
70 |
|
110 |
|
120 |
|
140 |
|
440 |
|
||||
| Revenue |
480 |
|
546 |
|
541 |
|
609 |
|
2,176 |
|
||||
| Adjusted EBITDA Margin |
14.6 |
% |
20.1 |
% |
22.2 |
% |
23.0 |
% |
20.2 |
% |
||||
| Xylem Inc. Non-GAAP Reconciliation | ||||||||||||||
| EBITDA and Adjusted EBITDA by Quarter | ||||||||||||||
| Applied Water | ||||||||||||||
| ($ Millions) | ||||||||||||||
|
2019 |
||||||||||||||
| Q1 | Q2 | Q3 | Q4 | Total | ||||||||||
| Pre-Tax Income |
57 |
|
62 |
|
119 |
|
||||||||
| Interest Expense (Income), net |
- |
|
- |
|
- |
|
||||||||
| Depreciation |
5 |
|
5 |
|
10 |
|
||||||||
| Amortization |
1 |
|
1 |
|
2 |
|
||||||||
| EBITDA |
63 |
|
68 |
|
- |
|
- |
|
131 |
|
||||
| Share-based Compensation |
1 |
|
- |
|
1 |
|
||||||||
| Restructuring & Realignment |
3 |
|
4 |
|
7 |
|
||||||||
| Adjusted EBITDA |
67 |
|
72 |
|
- |
|
- |
|
139 |
|
||||
| Revenue |
379 |
|
394 |
|
773 |
|
||||||||
| Adjusted EBITDA Margin |
17.7 |
% |
18.3 |
% |
18.0 |
% |
||||||||
|
2018 |
||||||||||||||
| Q1 | Q2 | Q3 | Q4 | Total | ||||||||||
| Pre-Tax Income |
50 |
|
61 |
|
60 |
|
66 |
|
237 |
|
||||
| Interest Expense (Income), net |
- |
|
- |
|
- |
|
- |
|
- |
|
||||
| Depreciation |
5 |
|
5 |
|
5 |
|
5 |
|
20 |
|
||||
| Amortization |
- |
|
1 |
|
1 |
|
- |
|
2 |
|
||||
| EBITDA |
55 |
|
67 |
|
66 |
|
71 |
|
259 |
|
||||
| Share-based Compensation |
1 |
|
1 |
|
- |
|
1 |
|
3 |
|
||||
| Restructuring & Realignment |
3 |
|
2 |
|
2 |
|
3 |
|
10 |
|
||||
| Adjusted EBITDA |
59 |
|
70 |
|
68 |
|
75 |
|
272 |
|
||||
| Revenue |
366 |
|
388 |
|
378 |
|
402 |
|
1,534 |
|
||||
| Adjusted EBITDA Margin |
16.1 |
% |
18.0 |
% |
18.0 |
% |
18.7 |
% |
17.7 |
% |
||||
| Xylem Inc. Non-GAAP Reconciliation | ||||||||||||||
| EBITDA and Adjusted EBITDA by Quarter | ||||||||||||||
| Measurement & Control Solutions | ||||||||||||||
| ($ Millions) | ||||||||||||||
|
2019 |
||||||||||||||
| Q1 | Q2 | Q3 | Q4 | Total | ||||||||||
| Pre-Tax Income |
16 |
|
26 |
|
42 |
|
||||||||
| Interest Expense (Income), net |
- |
|
- |
|
- |
|
||||||||
| Depreciation |
9 |
|
9 |
|
18 |
|
||||||||
| Amortization |
27 |
|
26 |
|
53 |
|
||||||||
| EBITDA |
52 |
|
61 |
|
- |
|
- |
|
113 |
|
||||
| Share-based Compensation |
1 |
|
2 |
|
3 |
|
||||||||
| Restructuring & Realignment |
8 |
|
8 |
|
16 |
|
||||||||
| Loss/(Gain) from sale of business |
(1 |
) |
- |
|
(1 |
) |
||||||||
| Special Charges |
4 |
|
- |
|
4 |
|
||||||||
| Adjusted EBITDA |
64 |
|
71 |
|
- |
|
- |
|
135 |
|
||||
| Revenue |
376 |
|
390 |
|
766 |
|
||||||||
| Adjusted EBITDA Margin |
17.0 |
% |
18.2 |
% |
17.6 |
% |
||||||||
|
2018 |
||||||||||||||
| Q1 | Q2 | Q3 | Q4 | Total | ||||||||||
| Pre-Tax Income |
33 |
|
28 |
|
33 |
|
23 |
|
117 |
|
||||
| Interest Expense (Income), net |
- |
|
- |
|
- |
|
(1 |
) |
(1 |
) |
||||
| Depreciation |
8 |
|
9 |
|
8 |
|
10 |
|
35 |
|
||||
| Amortization |
29 |
|
27 |
|
26 |
|
27 |
|
109 |
|
||||
| EBITDA |
70 |
|
64 |
|
67 |
|
59 |
|
260 |
|
||||
| Share-based Compensation |
1 |
|
1 |
|
1 |
|
1 |
|
4 |
|
||||
| Restructuring & Realignment |
8 |
|
3 |
|
4 |
|
3 |
|
18 |
|
||||
| Loss/(Gain) from sale of business |
- |
|
2 |
|
(2 |
) |
- |
|
- |
|
||||
| Special Charges |
2 |
|
1 |
|
- |
|
2 |
|
5 |
|
||||
| Adjusted EBITDA |
81 |
|
71 |
|
70 |
|
65 |
|
287 |
|
||||
| Revenue |
371 |
|
383 |
|
368 |
|
375 |
|
1,497 |
|
||||
| Adjusted EBITDA Margin |
21.8 |
% |
18.5 |
% |
19.0 |
% |
17.3 |
% |
19.2 |
% |
||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20190801005500/en/
Source:
Media
Houston Spencer +1 (914) 323-5723
Houston.Spencer@xyleminc.com
Investors
Matt Latino +1 (914) 323-5821
Matthew.Latino@xyleminc.com